2,4-Dichloropyrimidine-5-carbonitrile

Catalog No.: 
ACXOMT729
CAS No.: 
3177-24-0
Molecular Formula: 
C5HCl2N3
Molecular Weight: 
173.99
2,4-Dichloropyrimidine-5-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g95%$50.00In stockInquiry
25g95%$123.00In stockInquiry
100g95%$403.00In stockInquiry
500g95%$1561.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,4-Dichloropyrimidine-5-carbonitrile
IUPAC Name2,4-dichloropyrimidine-5-carbonitrile
MDL No.MFCD09746248
Molecular FormulaC5HCl2N3
Molecular Weight173.99
SMILESClC1=NC=C(C(=N1)Cl)C#N
InChI KeyKMHSUNDEGHRBNV-UHFFFAOYSA-N
Synonym2,4-Dichloro-5-cyanopyrimidine | 3177-24-0 | 2,4-dichloropyrimidine-5-carbonitrile | MFCD09746248 | Ironphthalocyanine | SCHEMBL9043 | 2,6-dichloro-5-cyanopyrimidine | DTXSID10554569 | KMHSUNDEGHRBNV-UHFFFAOYSA-N | BBL102592 | STL556395 | 2,4-dichloro-5-pyrimidinecarbonitrile |
CAS No.3177-24-0
PubChem CID14026907

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACXOMT729 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTBWV970 route compound structure diagram
    ACTBWV9701240390-28-6In Stock
  2. Then
  3. ACXOMT729 route product structure diagram
    ACXOMT7293177-24-0In Stock
Inquiry

2. ACXOMT729 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXOMT729 route product structure diagram
    ACXOMT7293177-24-0In Stock
Inquiry

3. ACXOMT729 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXOMT729 route product structure diagram
    ACXOMT7293177-24-0In Stock
Inquiry

Comments (0)